Скачать с ютуб The WHO’s 5th classification for AML: expanding the number of genetically defined categories в хорошем качестве

The WHO’s 5th classification for AML: expanding the number of genetically defined categories

Sanam Loghavi, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, provides insight into the 5th iteration of the World Health Organization's (WHO) classification for acute myeloid leukemia (AML), highlighting the shift from a blast numerical cutoff to genomic classification. This has resulted in an expansion of the number of genetically defined categories of AML to approximately 20, with only two subtypes (AML with CEBPA mutation or BCR-ABL translocation) still requiring a blast count of 20%. This interview took place at the 66th ASH Annual Meeting and Exposition, held in San Diego, CA. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.